0.84
AEON Biopharma, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
9.84
FY23:
6.22
FY24:
1.59
FY25:
3.40
(positive)
Change from FY21 to FY25
millions USD
FY21:
276
FY22:
0.94
FY23:
0.62
FY24:
1.55
FY25:
2.16
Total assets
Change from FY21 to FY25
millions USD
FY21:
277
FY22:
10.8
FY23:
6.85
FY24:
3.14
FY25:
5.56
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.83
FY22:
82.6
FY23:
13.0
FY24:
14.1
FY25:
6.90
(negative)
Change from FY21 to FY25
millions USD
FY21:
17.0
FY22:
60.7
FY23:
147
FY24:
17.6
FY25:
53.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.9
FY22:
−288
FY23:
−153
FY24:
−28.6
FY25:
−55.0
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
6.85
FY24:
3.14
FY25:
5.56
All amounts in millions USD